RAFAEL HOLDINGS, INC. Debt Instrument, Face Amount
RAFAEL HOLDINGS, INC. (RFL) had Debt Instrument, Face Amount of $500.00 thousand as of 2025-03-31, per its 10-Q filed 2025-06-11.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentFaceAmount · last filed 2025-06-11
- 2025-03-31: Debt Instrument, Face Amount $500.00K.
- 2024-01-31: Debt Instrument, Face Amount $9.38M.
- 2023-10-31: Debt Instrument, Face Amount $9.38M.
- 2023-07-31: Debt Instrument, Face Amount $9.38M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2025-03-31 | $500.00K 10-Q · filed 2025-06-11 |
| 2024-01-31 | $9.38M 10-Q · filed 2024-03-14 |
| 2023-10-31 | $9.38M 10-Q · filed 2023-12-14 |
| 2023-07-31 | $9.38M 10-Q · filed 2024-03-14 |
| 2023-03-21 | $2.00M 10-Q · filed 2023-06-13 |
| 2019-07-31 | $15.00M 10-K · filed 2020-10-29 |
| 2019-04-30 | $15.00M 10-Q · filed 2019-06-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |